Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
26.78
-0.34 (-1.25%)
At close: Jan 16, 2026, 4:00 PM EST
26.76
-0.02 (-0.07%)
After-hours: Jan 16, 2026, 7:10 PM EST

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22
7,556---
Enterprise Value
7,227---
Debt / Equity Ratio
0.89-1.53-11.041.08
Asset Turnover
-1.090.54-
Inventory Turnover
-5.244.48-
Quick Ratio
9.090.931.863.29
Current Ratio
9.931.302.553.77
Return on Equity (ROE)
---293.82%-
Return on Assets (ROA)
--42.48%-35.34%-
Return on Capital (ROIC)
--93.29%-55.45%-
Return on Capital Employed (ROCE)
-8.90%-144.20%-100.60%-54.40%
Buyback Yield / Dilution
-201.21%-1.59%-4.73%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q